Syncom Formulations (India) Ltd sees 7.59% stock gain, outperforms sector and benchmark index

Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, saw a positive trend in its stock performance on October 28, 2024. The stock gained 7.59%, outperforming the sector by 6.41%. This comes after two consecutive days of falling stock prices.

The stock reached an intraday high of Rs 19.55, a 6.77% increase, and an intraday low of Rs 17.77, a 2.95% decrease. The stock's moving averages show that it is currently higher than the 100-day and 200-day moving averages, but lower than the 5-day, 20-day, and 50-day moving averages.

According to MarketsMOJO, a leading stock analysis and recommendation platform, the stock call for Syncom Formulations (India) Ltd is 'Hold'. This recommendation is based on the stock's performance and market trends, without any mention of future potential or expert opinions.

In comparison to the Sensex, a benchmark index for the Indian stock market, Syncom Formulations (India) Ltd has shown a 1-day performance of 7.59%, while the Sensex has only gained 1.39%. In the past month, the stock has seen a -10.37% performance, while the Sensex has seen a -5.92% performance.

Overall, Syncom Formulations (India) Ltd has shown a positive trend in its stock performance, outperforming the sector and the benchmark index. However, it is important for investors to do their own research and make informed decisions before investing in any stock.